RE:RE:RE:RE:RE:I did have a sell order innavajojoe wrote: canyousayiii wrote: Eddie, it is approaching mid-September. There is nothing debatable about your prediction for the past July! The share price did not exceed $3, was actually below a buck at the end of July. Loosen the mask a bit, let the blood circulate more freely to your brain.
There are lots of posters who seem to have amnesia about what they posted in the past, hoping that people are dumb enough to believe what they say now. Everything posted here is worth what one pays for it, absolutely nothing. But, over time, at least it becomes clear who is honest and who isn't. What matters is what the company accomplishes, not what anyone posts on the internet. With that in mind, hopefully we get more info on the Health Canada testing of BioCloud, and maybe something juicier before the AGM. A nice sale, any sale above twos and threes, of BioCloud would be nice.
if only that's what I said. Poor sods just bringing more attention to how trolly they are. What I DID SAY was that IMO it would be $3 ish-$3+ in anticipation of HC results. You think (or pretend to think rather) that I meant july because that's when we thought we'd have HC results , but the month had nothing to do with my opinion/prediction. I even went out of my way to explain my thought process more than once. I'm thinking if this as the same type of play as a bio company waiting for clinical trial results. Even when there's no leak there's usually some kind of leak whether that be hints, employees, ancillary work connection, bankers etc etc etc.
To recap we don't have results yet and we are sitting $2.30-$2.40 mark. Unless we get surprise results next few trading days it's looking more and more every day like my opinion will turn out right .